Clinical considerations for estrogen receptor-negative/progesterone receptor-positive/HER2-negative (ER - PR + HER2 - ) breast cancer.
Bruno Henrique Rala de PaulaSusanne CrocamoJose BinesPublished in: Translational breast cancer research : a journal focusing on translational research in breast cancer (2022)